Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Promoter Reclassification

Bliss GVS Pharma Promoter Reclassification

Bliss GVS Pharma announced the reclassification of its erstwhile promoter group to the public category following a change in control via an open offer.

Source

BSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bliss GVS Pharma Ltd: key numbers

Share price
₹652.75
Market cap
₹6,944 Cr
Revenue (annual)
₹927.1 Cr
Net profit (annual)
₹129.1 Cr
P/E (TTM)
51.0×Sector 46.5×
Promoter holding
50.07%+15.06% QoQ
FII holding
5.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bliss GVS Pharma Ltd

All →

Other promoter reclassification announcements

All →